![John Stuelpnagel](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
John Stuelpnagel
Chairman at
10X GENOMICS, INC.
Net worth: 57 M $ as of 27/02/2026
Profile
John R. Stuelpnagel is an entrepreneur and businessperson who founded Illumina, Inc., Fabric Genomics, Inc. and Ariosa Diagnostics, Inc. and who has been the head of 6 different companies. He is Chairman for 10X Genomics, Inc., Chairman at Fabric Genomics, Inc., Chairman for Inscripta, Inc. and Chairman for Element Biosciences, Inc. John R. Stuelpnagel is also on the board of Federation Bio, Inc. and Encoded Therapeutics, Inc. In the past Dr. Stuelpnagel held the position of Chief Operating Officer & Director at Illumina, Inc., Associate at CW Group, Inc., BRD at Sequenta, Inc. and Executive Chairman of Ariosa Diagnostics, Inc. He received a doctorate and an undergraduate degree from the University of California, Davis and an MBA from the University of California, Los Angeles.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
10X GENOMICS INC 10.47% | 30/03/2025 | 2,105,736 ( 10.47% ) | 49 M $ | 27/02/2026 |
| 02/06/2025 | 359,607 ( 0.31% ) | 8 M $ | 27/02/2026 |
John Stuelpnagel active positions
| Companies | Position | Start |
|---|---|---|
| 10X GENOMICS, INC. | Chairman | 31/07/2013 |
Fabric Genomics, Inc.
 Fabric Genomics, Inc. Packaged SoftwareTechnology Services Develops AI-powered genomic interpretation platform | Founder | - |
Inscripta, Inc.
 Inscripta, Inc. BiotechnologyHealth Technology Develops biomanufacturing solutions | Chairman | 31/03/2017 |
Encoded Therapeutics, Inc.
 Encoded Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Encoded Therapeutics, Inc. operates as a biotechnology company that engages in the development of precision medicines and therapy for genetic disorders. It focuses on viral gene therapies. The company was founded by Kartik Ramamoorthi and Stephanie Tagliatela and is headquartered in South San Francisco, CA. | Director/Board Member | 30/04/2017 |
Federation Bio, Inc.
 Federation Bio, Inc. BiotechnologyHealth Technology Research and develops micro biome therapeutics | Director/Board Member | 31/05/2020 |
Venrock Associates
 Venrock Associates Investment ManagersFinance Venrock Associates invests in companies located in the US. The firm focuses on sectors such as intelligent enterprise & AI, security & infrastructure, fintech, healthcare IT, defense & Aerospace, robotics & autonomy and consumer sectors. It participates in early and later stage transactions. | Consultant / Advisor | 31/12/1997 |
Former positions of John Stuelpnagel
| Companies | Position | End |
|---|---|---|
Element Biosciences, Inc.
 Element Biosciences, Inc. BiotechnologyHealth Technology Develops DNA sequencing technology for the research and diagnostic markets | Chairman | 31/12/2022 |
| ADAPTIVE BIOTECHNOLOGIES CORPORATION | Director/Board Member | 31/10/2017 |
Ariosa Diagnostics, Inc.
 Ariosa Diagnostics, Inc. Medical/Nursing ServicesHealth Services Offers diagnostics and genetic testing services | Founder | 31/12/2014 |
| ░░░░░░░░░ ░░░░ | ░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
Training of John Stuelpnagel
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
85
1st degree connections
14
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 14 |
|---|---|
Venrock Associates
Venrock Associates Investment ManagersFinance Venrock Associates invests in companies located in the US. The firm focuses on sectors such as intelligent enterprise & AI, security & infrastructure, fintech, healthcare IT, defense & Aerospace, robotics & autonomy and consumer sectors. It participates in early and later stage transactions. | Finance |
Illumina, Inc.
 Illumina, Inc. Medical SpecialtiesHealth Technology Operates as a biotechnology company that develops laboratory instruments | Health Technology |
Sequenta, Inc.
 Sequenta, Inc. BiotechnologyHealth Technology Operates as a biotech company which discovers and develops clinical diagnostics based on immune system status | Health Technology |
10X Genomics, Inc.
 10X Genomics, Inc. BiotechnologyHealth Technology Develops integrated systems and solutions for genome sequencing, exome sequencing and single cell transcriptomics | Health Technology |
CW Group, Inc.
 CW Group, Inc. Investment ManagersFinance CW Group invests in companies located in the United States. The firm focuses on a broad range of sectors and industries. It provides financing for early stage capital requirements. | Finance |
University of California, Los Angeles
 University of California, Los Angeles Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Davis
 University of California, Davis Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Fabric Genomics, Inc.
Fabric Genomics, Inc. Packaged SoftwareTechnology Services Develops AI-powered genomic interpretation platform | Technology Services |
Ariosa Diagnostics, Inc.
Ariosa Diagnostics, Inc. Medical/Nursing ServicesHealth Services Offers diagnostics and genetic testing services | Health Services |
Adaptive Biotechnologies Corp.
 Adaptive Biotechnologies Corp. BiotechnologyHealth Technology Develops sequencing assays for the adaptive immune system | Health Technology |
Inscripta, Inc.
Inscripta, Inc. BiotechnologyHealth Technology Develops biomanufacturing solutions | Health Technology |
Federation Bio, Inc.
Federation Bio, Inc. BiotechnologyHealth Technology Research and develops micro biome therapeutics | Health Technology |
Element Biosciences, Inc.
Element Biosciences, Inc. BiotechnologyHealth Technology Develops DNA sequencing technology for the research and diagnostic markets | Health Technology |
Encoded Therapeutics, Inc.
Encoded Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Encoded Therapeutics, Inc. operates as a biotechnology company that engages in the development of precision medicines and therapy for genetic disorders. It focuses on viral gene therapies. The company was founded by Kartik Ramamoorthi and Stephanie Tagliatela and is headquartered in South San Francisco, CA. | Commercial Services |
- Stock Market
- Insiders
- John Stuelpnagel
